LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 63.60p on 21-11-2025 at 04:45:19 |
|---|---|
| Change | -0.40p -0.63% |
| Buy | 64.00p |
| Sell | 63.20p |
| Last Trade: | Unknown 225,000.00 at 63.85p |
| Day's Volume: | 0 |
| Last Close: | 63.60p |
| Open: | 64.40p |
| ISIN: | GB0005518872 |
| Day's Range | 63.60p - 65.00p |
| 52wk Range: | 63.20p - 122.00p |
| Market Capitalisation: | £99.89m |
| VWAP: | 0.00p |
| Shares in Issue: | 157.06m |
Macfarlane Grp. (MACF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 225,000 | 63.85p | Negotiated Trade |
16:40:45 - 20-Nov-25 |
| Buy* | 1,938 | 63.60p | Automatic Execution |
16:35:03 - 20-Nov-25 |
| Buy* | 9,963 | 63.60p | Suspected BUY Trade |
16:35:03 - 20-Nov-25 |
| Buy* | 782 | 63.88p | Ordinary |
16:26:06 - 20-Nov-25 |
| Buy* | 1,218 | 64.00p | Automatic Execution |
16:24:20 - 20-Nov-25 |
| Buy* | 5,938 | 64.00p | SI Trade |
16:23:56 - 20-Nov-25 |
| Buy* | 100 | 64.20p | SI Trade |
16:10:20 - 20-Nov-25 |
| Buy* | 425 | 64.20p | Automatic Execution |
16:02:44 - 20-Nov-25 |
| Buy* | 1,391 | 64.20p | Automatic Execution |
16:02:44 - 20-Nov-25 |
| Buy* | 6,343 | 64.00p | SI Trade |
15:57:41 - 20-Nov-25 |
Macfarlane Grp. (MACF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 10th Nov 2025 8:27 am | RNS | Holding(s) in Company |
| 10th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 3rd Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 31st Oct 2025 11:57 am | RNS | Holding(s) in Company |
| 31st Oct 2025 7:00 am | RNS | Transaction in Own Shares |
| 30th Oct 2025 7:00 am | RNS | Transaction in Own Shares |
| 29th Oct 2025 7:00 am | RNS | Transaction in Own Shares |
| 28th Oct 2025 7:00 am | RNS | Transaction in Own Shares |
| 27th Oct 2025 8:33 am | RNS | Holding(s) in Company |